Psilocybin Regulations Bill Advancing In Oregon Senate

The Oregon Senate Human Services, Mental Health, and Recovery Committee unanimously approved a measure to regulate the state’s emerging psilocybin program.

Full story after the jump.

An Oregon Senate committee has passed a proposal to ensure the state’s emerging psilocybin program grows in a socially equitable manner, Marijuana Moment reports. Sponsored by state Sen. Lawrence Spence (D) and Rep. Wlnsvey Campos (D), the bicameral measure passed the Senate Human Services, Mental Health and Recovery Committee unanimously, with two members excused, earlier this month.

The measure seeks to create a 15-person task force made up of lawmakers, psilocybin regulators, experienced psychedelics treatment practitioners, and representatives of the indigenous community. Only one committee, Ways and Means, remains between the bill and a floor vote in the Senate.

Voters in Oregon passed the ballot measure to legalize psilocybin for therapeutic purposes in 2020. The measure legalized the “manufacture, delivery and administration” of the psychedelic compounds and rules have begun to emerge from the advisory board in charge of creating the system to regulate the drug which shows the state is leaning toward allowing only one species of mushroom, Psilocybe cubensis, for psilocybin manufacturing.

Additionally, early reporting shows synthetic psilocybin would not be permitted in Oregon, according to Oregon Public Broadcasting.

“It is kind of a landmark moment because Oregon is the very first state to have created such a system of regulation,” Mason Marks, a member of Oregon’s psilocybin advisory board and a senior fellow on the Project on Psychedelics Law and Regulation at Harvard Law School said in the report. “These are the very first draft rules that we’re seeing, so it really is a kind of pivotal event.”

Get daily cannabis business news updates. Subscribe

Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.

Sponsor message:

End


Latest Cannabis News

View all news Get email updates

Create a profile View all categories

From Our Partners